본문으로 건너뛰기

Brief History

Over half a century since the foundation in 1968, Samjin Pharm has solidified its position by keeping the dignity of the pharmaceutical industry.

2020’s - 2011’s

Strived for the R&D of new drugs

2020

2011

  • 2020.10

    Digital healthcare startup 'Wellysis' business collaboration & investment agreement, entering into medical device business
  • 2020.07

    Open the official online store 'Market On J' and launch the healthcare brand 'Wish Healthy'
  • 2020.04

    R&D collaboration contract with Standigm to develop novel anti-cancer drugs using Artificial Intelligence-based drug discovery platform
  • 2019.04

    R&D collaboration contract with Korea Research Institute of Chemical Technology to develop novel targeted therapy of cancer and immunotherapy of cancer.
  • 2019.03

    Chang Hong Soon and Choi Yong Joo inaugurated for C.E.O and chairman
  • 2018.09

    R&D collaboration contract with AptaBio to develop novel therapeutics for the treatment of age-related macular degeneration
  • 2017.12

    R&D collaboration contract with Dept. of Pharmacy in Hanyang University to develop novel therapeutics for the treatment of Alzheimer’s disease
  • 2017.09

    Approval of clinical phase 2 by KFDA for oral xeroma treatment drug
  • 2017.02

    R&D collaboration contract with Korea Research Institute of Bioscience and Biotechnology to develop novel therapeutics for the treatment of Alzheimer’s disease and diabetes.
  • 2016.06

    R&D collaboration contract with Institut Pasteur Korea to develop novel therapeutics for the treatment of hepatocellular carcinoma.
  • 2016.03

    R&D collaboration contract with APTA Bio to develop novel targeted therapy of cancer
  • 2015.12

    R&D collaboration contract with Bioinformatics and Molecular Design Research Center to develop novel drugs
  • 2015.06

    Advancement of 10 raw materials of antithrombotic and other items and drug preparation techniques to Indonesia
  • 2015.04

    Approval of IND by KFDA for oral xeroma treatment
  • 2014.10

    Opened quality centers of Samjin Pharmaceuticals
  • 2014.10

    The governmental support for the development of a new drug ‘SA001‘ the oral xeroma treatment
  • 2014.07

    Approval of IND of Samjin Pharmaceuticals, the AIDS prevention drug for females by the US FDA
  • 2013.09

    Opening ceremony of Central Research Institute in Pangyo Techno Valley complex
  • 2013.03

    Completion of C.G.M.P Osong plant
  • 2012.06

    Selected as innovative pharmaceutical company

2010’s - 2001’s

Soaring through innovation and change

2010

2001

  • 2010.11

    Awarded the $ 3.0 million export trophy (47th trade day)
  • 2008.11

    Introduction of retirement pension
  • 2007.02

    Influenza & Hepatitis B Treatment New materials Patent application
  • 2006.09

    SARS bacteria New coronavirus Treatment New materials Patent application
  • 2006.02

    Hepatitis C Treatment New materials Patent application
  • 2005.05

    Project of research and development of cell application was selected by Ministry of Science and Technology
  • 2005.01

    Completion of office building of headquarters and moving in
  • 2004.02

    Awarded the Grand prize in the 16th [fruitful company] selected by Korea employers federation
  • 2003.07

    Started the construction of new office building of headquarters
  • 2001.11

    Awarded the $ 1.0 million export trophy (38th trade day)
  • 2001.09

    President Lee, Sung Woo was appointed

2000’s - 1991’s

Dreaming of new initiatives and jumps

2000

1991

  • 1999.

    “Geborin” was selected as the most preferred analgesic agent by customers on the 'Consumer News'
  • 1999.07

    Acquired American patent of medicine for AIDS and Y2K certification (Korea Management Association)
  • 1998.12

    Selected as one of top 10 companies by Hanmi Bank
  • 1997.07

    Awarded Silver Tower Industry Medal (Sector of Small and medium enterprises No. 502)
  • 1996.05

    Awarded the Steel Tower Decoration of Industrial Service Merit (Sector of labor management relation NO. 1179)
  • 1996.01

    International patent application for a remedy for solid tumor (Korea and 45 other countries)
  • 1993.05

    International patent application for a new analgesic anti- inflammatory agent (9 countries)

1990’s - 1981’s

Establishing a solid foothold in the
pharmaceutical industry

1990

1981

  • 1988.10

    Completion of a man-less automation warehouse
  • 1988.05

    A public opening of stocks (IPO shares, capital of 3 billion won at the time)
  • 1987.03

    Designated as place appropriate for K.G.M.P qualification (Ministry of Health and society NO. 19)
  • 1986.12

    Central Research laboratories designated as exemption for the military service (NO. 770)
  • 1985.11

    Completion of K.G.M.P Hyangnam plant
  • 1985.06

    Established and authorized the affiliated central research laboratory (Ministry of Science and Technology)
  • 1985.03

    Received the award from President (sector of exemplary industrialist/NO. 62408)
  • 1984.10

    Awarded ('84) grand prize in productivity
  • 1984.03

    Established Korean Federation of Community Credit
  • 1983.03

    Received the recognition from the Minister of Finance (sector in an exemplary taxpayer)

1980’s - 1968’s

Take the first step forward for Samjin

1980

1968

  • 1977.12

    Implementation of Samjin Gold Prize System (sectors of Creation, pioneering and Advance)
  • 1977.03

    Implementation of a five day working system
  • 1976.07

    Launching Samjin Scholarship foundation
  • 1972.11

    Acquired DaeHan Changgi Pharm Co., Ltd and renamed to Samjin Pharm Co., Ltd
  • 1970.12

    Established Samjin trading company (Wholesaler for pharmaceutical products, license No. 12)